Rokit Healthcare Inc
Company Profile
Business description
Rokit Healthcare Inc is a Pioneer that transforms the healthcare paradigm. The company upgrades and expands the life span with its hyper-personal organ regeneration & anti-aging platform. All patients are different since all humans are heterogeneous. There is no single therapy for all patients, so the company provides suffering patients and humans with a hyper-personalized medical organ regeneration solution. Based on its expertise in regenerative medicine, it is commercializing a safer, more effective, and faster organ regeneration platform around the world. Its products include Dr. INVIVO 4D2, Dr. INVIVO 4D6, and Dr. INVIVO EDU.
Contact
Digital-ro 10-gil 9
Gasan High-hill Building, 12th Floor
Geumcheon-gu
Seoul08514
KORT: +82 18997296
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2026
Employees
79
Stocks News & Analysis
stocks
Our view on oil prices after Maduro is deposed
stocks
Nvidia: Full steam ahead with an impressive array of announcements at CES 2026
stocks
Cheapest ASX member of our Best Idea’s list
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,018.00 | 21.50 | -0.24% |
| CAC 40 | 8,237.43 | 25.93 | 0.32% |
| DAX 40 | 24,892.20 | 23.51 | 0.09% |
| Dow JONES (US) | 49,462.08 | 484.90 | 0.99% |
| FTSE 100 | 10,122.73 | 118.16 | 1.18% |
| HKSE | 26,710.45 | 363.21 | 1.38% |
| NASDAQ | 23,547.17 | 151.35 | 0.65% |
| Nikkei 225 | 52,258.57 | 259.51 | -0.49% |
| NZX 50 Index | 13,699.26 | 35.68 | 0.26% |
| S&P 500 | 6,944.82 | 42.77 | 0.62% |
| S&P/ASX 200 | 8,700.40 | 23.10 | -0.26% |
| SSE Composite Index | 4,083.67 | 60.25 | 1.50% |